Xilio Therapeutics is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment. The Scientist, In Vivo Pharmacology is a key contributor in Xilio's In Vivo Pharmacology group. This person is responsible for developing and running in vivo oncology efficacy models, and pharmacokinetic and pharmacodynamic studies for the characterization of immuno-oncology focused protein therapeutics. The Scientist, In Vivo Pharmacology collaborates with internal team members to successfully execute studies. This important role will have the opportunity to represent in vivo pharmacology on project teams and reports directly to the Sr. Director, In Vivo Pharmacology.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Industry
Professional, Scientific, and Technical Services
Education Level
Ph.D. or professional degree